The Valley Desk

NCT05262023 · Interventional trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN)

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Frontotemporal Dementia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov